Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stefano Molica, Gaetano Vitelli, Rosanna Mirabelli, Giovanna Digiesu, Diana Giannarelli, Antonio Cuneo, Domenico Ribatti & Angelo Vacca. (2006) Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease. Leukemia & Lymphoma 47:6, pages 1034-1040.
Read now
Read now
Articles from other publishers (12)
Katalin Karászi, Renáta Vigh, Miklós Máthé, Alexandra Fullár, Lászlóné Oláh, Tibor Füle, Zoltán Papp & Ilona Kovalszky. (2020) Aberrant Expression of Syndecan-1 in Cervical Cancers. Pathology & Oncology Research 26:4, pages 2255-2264.
Crossref
Crossref
Randa F. Salam, Noha M. Khalil, Alshaimaa R. Alnaggar, Osama Mohamady, Amina Maher & Laila Ahmed Rashid. (2019) Role of syndecan-1 (CD138) in Egyptian systemic lupus erythematosus patients with lupus nephritis: Relation to disease activity. The Egyptian Rheumatologist 41:4, pages 289-294.
Crossref
Crossref
Monica SharmaSeema TyagiPreeti TripathiTulika Seth. (2018) Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations. Blood Research 53:3, pages 205.
Crossref
Crossref
Guilan Hu, Yanru Ma, Yonghong Dang, Fang Li & Li Huo. (2016) Solitary Plasmacytoma in the Renal Pelvis on 18F-FDG and 11C-Acetate PET/CT. Clinical Nuclear Medicine 41:5, pages 407-409.
Crossref
Crossref
G. S. GuptaAnita Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications
213
243
.
Miklós Máthé, Zsuzsanna Suba, Zsolt Németh, Péter Tátrai, Tibor Füle, Gábor Borgulya, József Barabás & Ilona Kovalszky. (2006) Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncology 42:5, pages 493-500.
Crossref
Crossref
Kiyoshi Takatsu, Byoung-gon Moon, Atsuko Itakura, Yumiko Tsukamoto, Keisuke Horikawa, Masashi Ikutani, Taku Kouro & Satoshi Takaki. (2005) Role of IL-5 in the innate immune system and disease control. International Congress Series 1285, pages 145-154.
Crossref
Crossref
Yumiko Tsukamoto, Shoji Uehara, Chieko Mizoguchi, Atsushi Sato, Keisuke Horikawa & Kiyoshi Takatsu. (2005) Requirement of 8-mercaptoguanosine as a costimulus for IL-4-dependent μ to γ1 class switch recombination in CD38-activated B cells. Biochemical and Biophysical Research Communications 336:2, pages 625-633.
Crossref
Crossref
Kiyoshi Takatsu. (2005) Interleukin-5: Modulator of innate and acquired immunity. Ensho Saisei 25:6, pages 482-491.
Crossref
Crossref
D M Kofler, H Büning, C Mayr, D Bund, J Baumert, M Hallek & C-M Wendtner. (2004) Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 11:18, pages 1416-1424.
Crossref
Crossref
Jhagvaral Hasbold, Lynn M Corcoran, David M Tarlinton, Stuart G Tangye & Philip D Hodgkin. (2003) Evidence from the generation of immunoglobulin G–secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nature Immunology 5:1, pages 55-63.
Crossref
Crossref
József Tı́már, Károly Lapis, József Dudás, Anna Sebestyén, László Kopper & Ilona Kovalszky. (2002) Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology 12:3, pages 173-186.
Crossref
Crossref